25 XP   0   0   10

Nath Bio-Genes (India) Limited
Buy, Hold or Sell?

Let's analyse Nath Bio-Genes (India) Limited together

PenkeI guess you are interested in Nath Bio-Genes (India) Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nath Bio-Genes (India) Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nath Bio-Genes (India) Limited

I send you an email if I find something interesting about Nath Bio-Genes (India) Limited.

Quick analysis of Nath Bio-Genes (India) Limited (30 sec.)










What can you expect buying and holding a share of Nath Bio-Genes (India) Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.10
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
INR301.61
Expected worth in 1 year
INR367.29
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR73.68
Return On Investment
35.5%

For what price can you sell your share?

Current Price per Share
INR207.40
Expected price per share
INR171.25 - INR223.80
How sure are you?
50%

1. Valuation of Nath Bio-Genes (India) Limited (5 min.)




Live pricePrice per Share (EOD)

INR207.40

Intrinsic Value Per Share

INR44.88 - INR445.62

Total Value Per Share

INR346.48 - INR747.23

2. Growth of Nath Bio-Genes (India) Limited (5 min.)




Is Nath Bio-Genes (India) Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$68.7m$65m$3.7m5.4%

How much money is Nath Bio-Genes (India) Limited making?

Current yearPrevious yearGrowGrow %
Making money$4.2m-$8m$12.2m292.3%
Net Profit Margin11.6%-24.2%--

How much money comes from the company's main activities?

3. Financial Health of Nath Bio-Genes (India) Limited (5 min.)




4. Comparing to competitors in the Agricultural Inputs industry (5 min.)




  Industry Rankings (Agricultural Inputs)  


Richest
#114 / 157

Most Revenue
#117 / 157

Most Profit
#93 / 157

What can you expect buying and holding a share of Nath Bio-Genes (India) Limited? (5 min.)

Welcome investor! Nath Bio-Genes (India) Limited's management wants to use your money to grow the business. In return you get a share of Nath Bio-Genes (India) Limited.

What can you expect buying and holding a share of Nath Bio-Genes (India) Limited?

First you should know what it really means to hold a share of Nath Bio-Genes (India) Limited. And how you can make/lose money.

Speculation

The Price per Share of Nath Bio-Genes (India) Limited is INR207.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nath Bio-Genes (India) Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nath Bio-Genes (India) Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR301.61. Based on the TTM, the Book Value Change Per Share is INR16.42 per quarter. Based on the YOY, the Book Value Change Per Share is INR-37.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR2.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nath Bio-Genes (India) Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.220.1%0.220.1%-0.43-0.2%0.140.1%0.140.1%
Usd Book Value Change Per Share0.200.1%0.200.1%-0.45-0.2%0.130.1%0.330.2%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.020.0%0.010.0%
Usd Total Gains Per Share0.220.1%0.220.1%-0.43-0.2%0.160.1%0.340.2%
Usd Price Per Share1.70-1.70-2.56-3.00-2.53-
Price to Earnings Ratio7.67-7.67--6.02-7.96-11.09-
Price-to-Total Gains Ratio7.67-7.67--6.01-7.36-8.37-
Price to Book Ratio0.47-0.47-0.75-0.87-1.37-
Price-to-Total Gains Ratio7.67-7.67--6.01-7.36-8.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.4888
Number of shares401
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.200.13
Usd Total Gains Per Share0.220.16
Gains per Quarter (401 shares)88.6462.26
Gains per Year (401 shares)354.54249.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13831634538211239
27763270077421488
31159481055115632737
415412641410154842986
51921580176519210531235
62311896212023112631484
72692212247526914741733
83082528283030816841982
93462844318534618952231
103853160354038521062480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.05.050.0%5.00.06.045.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%

Fundamentals of Nath Bio-Genes (India) Limited

About Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company offers its products through a network of distributors, dealers, branch offices, conditioned warehouses, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.

Fundamental data was last updated by Penke on 2024-04-14 05:20:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Nath Bio-Genes (India) Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nath Bio-Genes (India) Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Nath Bio-Genes (India) Limited to the Agricultural Inputs industry mean.
  • A Net Profit Margin of 11.6% means that ₹0.12 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 11.6%. The company is making a huge profit. +2
  • The TTM is 11.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.6%TTM11.6%0.0%
TTM11.6%YOY-24.2%+35.8%
TTM11.6%5Y8.0%+3.6%
5Y8.0%10Y10.0%-2.0%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6%4.9%+6.7%
TTM11.6%5.3%+6.3%
YOY-24.2%7.9%-32.1%
5Y8.0%5.4%+2.6%
10Y10.0%3.9%+6.1%
1.1.2. Return on Assets

Shows how efficient Nath Bio-Genes (India) Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nath Bio-Genes (India) Limited to the Agricultural Inputs industry mean.
  • 4.4% Return on Assets means that Nath Bio-Genes (India) Limited generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY-9.1%+13.5%
TTM4.4%5Y3.1%+1.4%
5Y3.1%10Y5.5%-2.5%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%3.1%+1.3%
TTM4.4%3.0%+1.4%
YOY-9.1%3.5%-12.6%
5Y3.1%1.8%+1.3%
10Y5.5%1.5%+4.0%
1.1.3. Return on Equity

Shows how efficient Nath Bio-Genes (India) Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nath Bio-Genes (India) Limited to the Agricultural Inputs industry mean.
  • 6.1% Return on Equity means Nath Bio-Genes (India) Limited generated ₹0.06 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 6.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.1%0.0%
TTM6.1%YOY-12.4%+18.5%
TTM6.1%5Y3.9%+2.2%
5Y3.9%10Y10.3%-6.4%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%5.7%+0.4%
TTM6.1%5.5%+0.6%
YOY-12.4%7.6%-20.0%
5Y3.9%4.8%-0.9%
10Y10.3%3.9%+6.4%

1.2. Operating Efficiency of Nath Bio-Genes (India) Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nath Bio-Genes (India) Limited is operating .

  • Measures how much profit Nath Bio-Genes (India) Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nath Bio-Genes (India) Limited to the Agricultural Inputs industry mean.
  • An Operating Margin of 15.4% means the company generated ₹0.15  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 15.4%. The company is operating efficient. +1
  • The TTM is 15.4%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ15.4%TTM15.4%0.0%
TTM15.4%YOY12.7%+2.7%
TTM15.4%5Y17.5%-2.1%
5Y17.5%10Y16.7%+0.9%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ15.4%9.2%+6.2%
TTM15.4%7.4%+8.0%
YOY12.7%10.7%+2.0%
5Y17.5%8.2%+9.3%
10Y16.7%6.5%+10.2%
1.2.2. Operating Ratio

Measures how efficient Nath Bio-Genes (India) Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • An Operation Ratio of 0.85 means that the operating costs are ₹0.85 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 0.848. The company is less efficient in keeping operating costs low.
  • The TTM is 0.848. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.848TTM0.8480.000
TTM0.848YOY0.875-0.028
TTM0.8485Y0.828+0.020
5Y0.82810Y0.831-0.004
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8481.564-0.716
TTM0.8481.589-0.741
YOY0.8751.446-0.571
5Y0.8281.564-0.736
10Y0.8311.314-0.483

1.3. Liquidity of Nath Bio-Genes (India) Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nath Bio-Genes (India) Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A Current Ratio of 2.41 means the company has ₹2.41 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 2.406. The company is able to pay all its short-term debts. +1
  • The TTM is 2.406. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.406TTM2.4060.000
TTM2.406YOY2.391+0.015
TTM2.4065Y2.726-0.320
5Y2.72610Y2.401+0.325
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4061.609+0.797
TTM2.4061.628+0.778
YOY2.3911.688+0.703
5Y2.7261.763+0.963
10Y2.4011.637+0.764
1.3.2. Quick Ratio

Measures if Nath Bio-Genes (India) Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nath Bio-Genes (India) Limited to the Agricultural Inputs industry mean.
  • A Quick Ratio of 2.23 means the company can pay off ₹2.23 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 2.232. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.232. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.232TTM2.2320.000
TTM2.232YOY1.270+0.962
TTM2.2325Y1.594+0.639
5Y1.59410Y1.248+0.345
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2320.535+1.697
TTM2.2320.621+1.611
YOY1.2700.684+0.586
5Y1.5940.757+0.837
10Y1.2480.803+0.445

1.4. Solvency of Nath Bio-Genes (India) Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nath Bio-Genes (India) Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nath Bio-Genes (India) Limited to Agricultural Inputs industry mean.
  • A Debt to Asset Ratio of 0.28 means that Nath Bio-Genes (India) Limited assets are financed with 27.7% credit (debt) and the remaining percentage (100% - 27.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 0.277. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.277. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.277TTM0.2770.000
TTM0.277YOY0.269+0.008
TTM0.2775Y0.244+0.033
5Y0.24410Y0.356-0.112
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2770.448-0.171
TTM0.2770.450-0.173
YOY0.2690.456-0.187
5Y0.2440.479-0.235
10Y0.3560.496-0.140
1.4.2. Debt to Equity Ratio

Measures if Nath Bio-Genes (India) Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nath Bio-Genes (India) Limited to the Agricultural Inputs industry mean.
  • A Debt to Equity ratio of 38.3% means that company has ₹0.38 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nath Bio-Genes (India) Limited:

  • The MRQ is 0.383. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.383. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.383TTM0.3830.000
TTM0.383YOY0.369+0.014
TTM0.3835Y0.324+0.059
5Y0.32410Y0.657-0.333
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3830.799-0.416
TTM0.3830.810-0.427
YOY0.3690.872-0.503
5Y0.3240.967-0.643
10Y0.6571.065-0.408

2. Market Valuation of Nath Bio-Genes (India) Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Nath Bio-Genes (India) Limited generates.

  • Above 15 is considered overpriced but always compare Nath Bio-Genes (India) Limited to the Agricultural Inputs industry mean.
  • A PE ratio of 7.67 means the investor is paying ₹7.67 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nath Bio-Genes (India) Limited:

  • The EOD is 11.258. Based on the earnings, the company is underpriced. +1
  • The MRQ is 7.667. Based on the earnings, the company is underpriced. +1
  • The TTM is 7.667. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD11.258MRQ7.667+3.591
MRQ7.667TTM7.6670.000
TTM7.667YOY-6.021+13.688
TTM7.6675Y7.955-0.288
5Y7.95510Y11.088-3.133
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD11.2588.054+3.204
MRQ7.6679.200-1.533
TTM7.66710.599-2.932
YOY-6.02111.668-17.689
5Y7.95515.306-7.351
10Y11.08820.446-9.358
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nath Bio-Genes (India) Limited:

  • The EOD is 11.004. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.494. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.494. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD11.004MRQ7.494+3.510
MRQ7.494TTM7.4940.000
TTM7.494YOY-102.121+109.615
TTM7.4945Y-41.404+48.899
5Y-41.40410Y-53.416+12.012
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD11.0040.371+10.633
MRQ7.4940.372+7.122
TTM7.4940.005+7.489
YOY-102.1210.786-102.907
5Y-41.4040.582-41.986
10Y-53.4160.142-53.558
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nath Bio-Genes (India) Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A PB ratio of 0.47 means the investor is paying ₹0.47 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Nath Bio-Genes (India) Limited:

  • The EOD is 0.688. Based on the equity, the company is cheap. +2
  • The MRQ is 0.468. Based on the equity, the company is cheap. +2
  • The TTM is 0.468. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.688MRQ0.468+0.219
MRQ0.468TTM0.4680.000
TTM0.468YOY0.748-0.280
TTM0.4685Y0.867-0.398
5Y0.86710Y1.367-0.500
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD0.6881.403-0.715
MRQ0.4681.559-1.091
TTM0.4681.666-1.198
YOY0.7482.402-1.654
5Y0.8671.954-1.087
10Y1.3672.656-1.289
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nath Bio-Genes (India) Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--16.42016.4200%-37.523+329%10.939+50%27.136-39%
Book Value Per Share--301.607301.6070%285.187+6%294.003+3%195.257+54%
Current Ratio--2.4062.4060%2.391+1%2.726-12%2.401+0%
Debt To Asset Ratio--0.2770.2770%0.269+3%0.244+14%0.356-22%
Debt To Equity Ratio--0.3830.3830%0.369+4%0.324+18%0.657-42%
Dividend Per Share--2.0002.0000%2.0000%2.0000%1.000+100%
Eps--18.42318.4230%-35.434+292%11.814+56%11.672+58%
Free Cash Flow Per Share--18.84818.8480%-2.089+111%-3.121+117%-5.256+128%
Free Cash Flow To Equity Per Share--17.97017.9700%-13.785+177%-1.204+107%2.084+762%
Gross Profit Margin---1.022-1.0220%1.294-179%0.390-362%0.169-706%
Intrinsic Value_10Y_max--445.623--------
Intrinsic Value_10Y_min--44.877--------
Intrinsic Value_1Y_max--12.595--------
Intrinsic Value_1Y_min---2.825--------
Intrinsic Value_3Y_max--62.275--------
Intrinsic Value_3Y_min---2.198--------
Intrinsic Value_5Y_max--141.413--------
Intrinsic Value_5Y_min--5.321--------
Market Cap3941429600.000+32%2684315000.0002684315000.0000%4054503400.000-34%4754610760.000-44%4002432440.000-33%
Net Profit Margin--0.1160.1160%-0.242+308%0.080+44%0.100+16%
Operating Margin--0.1540.1540%0.127+21%0.175-12%0.167-8%
Operating Ratio--0.8480.8480%0.875-3%0.828+2%0.831+2%
Pb Ratio0.688+32%0.4680.4680%0.748-37%0.867-46%1.367-66%
Pe Ratio11.258+32%7.6677.6670%-6.021+179%7.955-4%11.088-31%
Price Per Share207.400+32%141.250141.2500%213.350-34%250.190-44%210.610-33%
Price To Free Cash Flow Ratio11.004+32%7.4947.4940%-102.121+1463%-41.404+652%-53.416+813%
Price To Total Gains Ratio11.260+32%7.6687.6680%-6.006+178%7.362+4%8.373-8%
Quick Ratio--2.2322.2320%1.270+76%1.594+40%1.248+79%
Return On Assets--0.0440.0440%-0.091+306%0.031+45%0.055-20%
Return On Equity--0.0610.0610%-0.124+303%0.039+58%0.103-40%
Total Gains Per Share--18.42018.4200%-35.523+293%12.939+42%28.136-35%
Usd Book Value--68780796.00068780796.0000%65036328.000+6%67046864.045+3%44527865.555+54%
Usd Book Value Change Per Share--0.1970.1970%-0.450+329%0.131+50%0.326-39%
Usd Book Value Per Share--3.6193.6190%3.422+6%3.528+3%2.343+54%
Usd Dividend Per Share--0.0240.0240%0.0240%0.0240%0.012+100%
Usd Eps--0.2210.2210%-0.425+292%0.142+56%0.140+58%
Usd Free Cash Flow--4298160.0004298160.0000%-476436.000+111%-711625.853+117%-1198545.574+128%
Usd Free Cash Flow Per Share--0.2260.2260%-0.025+111%-0.037+117%-0.063+128%
Usd Free Cash Flow To Equity Per Share--0.2160.2160%-0.165+177%-0.014+107%0.025+762%
Usd Market Cap47297155.200+32%32211780.00032211780.0000%48654040.800-34%57055329.120-44%48029189.280-33%
Usd Price Per Share2.489+32%1.6951.6950%2.560-34%3.002-44%2.527-33%
Usd Profit--4201368.0004201368.0000%-8080560.000+292%2694059.952+56%2661868.578+58%
Usd Revenue--36154980.00036154980.0000%33403260.000+8%33538526.174+8%27547785.166+31%
Usd Total Gains Per Share--0.2210.2210%-0.426+293%0.155+42%0.338-35%
 EOD+4 -4MRQTTM+0 -0YOY+26 -85Y+24 -1010Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of Nath Bio-Genes (India) Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.258
Price to Book Ratio (EOD)Between0-10.688
Net Profit Margin (MRQ)Greater than00.116
Operating Margin (MRQ)Greater than00.154
Quick Ratio (MRQ)Greater than12.232
Current Ratio (MRQ)Greater than12.406
Debt to Asset Ratio (MRQ)Less than10.277
Debt to Equity Ratio (MRQ)Less than10.383
Return on Equity (MRQ)Greater than0.150.061
Return on Assets (MRQ)Greater than0.050.044
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Nath Bio-Genes (India) Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.523
Ma 20Greater thanMa 50191.625
Ma 50Greater thanMa 100196.026
Ma 100Greater thanMa 200203.381
OpenGreater thanClose201.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets7,927,970
Total Liabilities2,196,237
Total Stockholder Equity5,731,733
 As reported
Total Liabilities 2,196,237
Total Stockholder Equity+ 5,731,733
Total Assets = 7,927,970

Assets

Total Assets7,927,970
Total Current Assets5,208,318
Long-term Assets2,719,652
Total Current Assets
Cash And Cash Equivalents 379,952
Short-term Investments 1,709,287
Net Receivables 1,033,625
Inventory 2,078,466
Other Current Assets 6,988
Total Current Assets  (as reported)5,208,318
Total Current Assets  (calculated)5,208,318
+/-0
Long-term Assets
Property Plant Equipment 2,339,595
Intangible Assets 104,174
Long-term Assets Other 225,401
Long-term Assets  (as reported)2,719,652
Long-term Assets  (calculated)2,669,170
+/- 50,482

Liabilities & Shareholders' Equity

Total Current Liabilities2,164,534
Long-term Liabilities31,703
Total Stockholder Equity5,731,733
Total Current Liabilities
Short-term Debt 1,048,091
Short Long Term Debt 1,048,091
Accounts payable 277,356
Other Current Liabilities 830,376
Total Current Liabilities  (as reported)2,164,534
Total Current Liabilities  (calculated)3,203,914
+/- 1,039,380
Long-term Liabilities
Long term Debt Total 4,032
Other Liabilities 27,868
Long-term Liabilities  (as reported)31,703
Long-term Liabilities  (calculated)31,900
+/- 197
Total Stockholder Equity
Common Stock190,040
Retained Earnings 4,056,568
Accumulated Other Comprehensive Income 150,126
Capital Surplus 1,335,000
Total Stockholder Equity (as reported)5,731,733
Total Stockholder Equity (calculated)5,731,734
+/- 1
Other
Capital Stock190,040
Cash And Equivalents49
Cash and Short Term Investments 2,089,239
Common Stock Shares Outstanding 19,004
Current Deferred Revenue8,711
Liabilities and Stockholders Equity 7,927,970
Net Debt 672,171
Net Invested Capital 6,783,856
Net Tangible Assets 5,627,559
Net Working Capital 3,043,784
Property Plant and Equipment Gross 2,339,595
Short Long Term Debt Total 1,052,123



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-31
> Total Assets 
1,199,552
1,582,828
1,899,283
2,261,434
2,667,002
2,893,542
5,712,049
6,460,634
7,299,457
7,895,100
7,419,082
7,927,970
7,927,9707,419,0827,895,1007,299,4576,460,6345,712,0492,893,5422,667,0022,261,4341,899,2831,582,8281,199,552
   > Total Current Assets 
962,201
1,197,496
1,592,512
1,977,312
2,252,703
2,419,375
3,542,065
4,071,795
4,771,613
5,238,928
4,701,703
5,208,318
5,208,3184,701,7035,238,9284,771,6134,071,7953,542,0652,419,3752,252,7031,977,3121,592,5121,197,496962,201
       Cash And Cash Equivalents 
32,909
24,801
22,135
15,721
12,245
58,470
446,583
213,793
219,799
292,111
41,680
379,952
379,95241,680292,111219,799213,793446,58358,47012,24515,72122,13524,80132,909
       Short-term Investments 
0
0
49,940
49,940
49,940
0
0
-14,425
215,001
0
152
1,709,287
1,709,2871520215,001-14,4250049,94049,94049,94000
       Net Receivables 
0
0
358,902
457,337
453,115
1,055,514
1,815,443
2,304,440
1,100,178
2,683,818
2,456,594
1,033,625
1,033,6252,456,5942,683,8181,100,1782,304,4401,815,4431,055,514453,115457,337358,90200
       Inventory 
657,557
771,745
885,684
1,170,349
1,407,398
1,301,509
1,234,572
1,553,562
2,043,081
2,262,999
2,203,427
2,078,466
2,078,4662,203,4272,262,9992,043,0811,553,5621,234,5721,301,5091,407,3981,170,349885,684771,745657,557
       Other Current Assets 
271,735
400,950
634,753
741,301
783,121
1,059,395
1,860,910
0
2,508,733
0
2
6,988
6,988202,508,73301,860,9101,059,395783,121741,301634,753400,950271,735
   > Long-term Assets 
237,351
385,332
306,771
284,122
414,298
474,168
2,169,984
2,388,839
2,527,844
2,656,172
2,717,379
2,719,652
2,719,6522,717,3792,656,1722,527,8442,388,8392,169,984474,168414,298284,122306,771385,332237,351
       Property Plant Equipment 
58,681
259,818
82,411
78,538
284,329
415,538
2,069,368
2,281,043
2,308,524
2,332,961
2,328,519
2,339,595
2,339,5952,328,5192,332,9612,308,5242,281,0432,069,368415,538284,32978,53882,411259,81858,681
       Long Term Investments 
0
0
21
23
26
49,968
49,970
49,973
0
0
0
0
000049,97349,97049,96826232100
       Intangible Assets 
0
0
82,941
49,416
20,245
0
40,000
36,000
151,650
136,188
120,263
104,174
104,174120,263136,188151,65036,00040,000020,24549,41682,94100
       Long-term Assets Other 
170,045
116,484
181,988
195,526
150,952
50,089
51,996
157
10,757
0
-2
225,401
225,401-2010,75715751,99650,089150,952195,526181,988116,484170,045
> Total Liabilities 
742,268
1,008,087
1,081,502
1,190,069
1,453,962
1,517,678
1,019,737
1,384,827
1,723,285
1,762,312
1,999,388
2,196,237
2,196,2371,999,3881,762,3121,723,2851,384,8271,019,7371,517,6781,453,9621,190,0691,081,5021,008,087742,268
   > Total Current Liabilities 
720,401
981,158
1,050,866
1,163,335
1,286,098
1,296,942
997,854
1,360,904
1,696,200
1,730,038
1,966,635
2,164,534
2,164,5341,966,6351,730,0381,696,2001,360,904997,8541,296,9421,286,0981,163,3351,050,866981,158720,401
       Short-term Debt 
81,647
171,156
196,118
201,843
430,448
486,088
322,733
576,425
698,499
959,137
922,938
1,048,091
1,048,091922,938959,137698,499576,425322,733486,088430,448201,843196,118171,15681,647
       Short Long Term Debt 
0
0
230,181
13,112
7,519
486,088
322,733
576,425
698,499
943,718
922,938
1,048,091
1,048,091922,938943,718698,499576,425322,733486,0887,51913,112230,18100
       Accounts payable 
163,605
276,142
392,638
515,585
479,514
443,528
365,993
502,013
682,057
452,328
550,875
277,356
277,356550,875452,328682,057502,013365,993443,528479,514515,585392,638276,142163,605
       Other Current Liabilities 
475,149
533,860
462,110
445,907
376,136
367,326
279,632
277,221
16,528
0
63,644
830,376
830,37663,644016,528277,221279,632367,326376,136445,907462,110533,860475,149
   > Long-term Liabilities 
21,867
26,929
30,636
26,734
167,864
220,736
21,884
23,923
27,086
32,274
32,753
31,703
31,70332,75332,27427,08623,92321,884220,736167,86426,73430,63626,92921,867
       Long term Debt Total 
0
0
0
0
150,000
200,671
3,101
5,046
2,996
6,528
6,648
4,032
4,0326,6486,5282,9965,0463,101200,671150,0000000
       Other Liabilities 
0
0
16,456
19,267
17,864
20,065
18,782
18,877
24,090
25,746
26,105
27,868
27,86826,10525,74624,09018,87718,78220,06517,86419,26716,45600
> Total Stockholder Equity
457,284
574,741
817,781
1,071,365
1,213,040
1,375,864
4,692,312
5,075,807
5,576,172
6,132,788
5,419,695
5,731,733
5,731,7335,419,6956,132,7885,576,1725,075,8074,692,3121,375,8641,213,0401,071,365817,781574,741457,284
   Common Stock
160,040
160,040
160,040
160,040
160,040
160,040
190,040
190,040
190,040
190,040
190,040
190,040
190,040190,040190,040190,040190,040190,040160,040160,040160,040160,040160,040160,040
   Retained Earnings 
141,144
258,601
501,641
755,225
896,899
1,059,724
3,011,171
3,394,667
3,895,031
4,456,123
3,744,735
4,056,568
4,056,5683,744,7354,456,1233,895,0313,394,6673,011,1711,059,724896,899755,225501,641258,601141,144
   Accumulated Other Comprehensive Income 
-119,191
-127,481
-138,034
0
-155,663
-163,196
-169,878
-177,419
-180,727
151,625
149,920
150,126
150,126149,920151,625-180,727-177,419-169,878-163,196-155,6630-138,034-127,481-119,191
   Capital Surplus 
0
0
0
0
0
0
0
1,335,000
1,335,000
1,335,000
1,335,000
1,335,000
1,335,0001,335,0001,335,0001,335,0001,335,0000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
275,292
283,581
294,134
156,100
311,763
319,296
1,660,978
1,668,520
-4,114,771
1,335,000
1,335,000
1,334,999
1,334,9991,335,0001,335,000-4,114,7711,668,5201,660,978319,296311,763156,100294,134283,581275,292



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue3,012,915
Cost of Revenue-1,345,916
Gross Profit1,666,9991,666,999
 
Operating Income (+$)
Gross Profit1,666,999
Operating Expense-1,208,215
Operating Income457,336458,784
 
Operating Expense (+$)
Research Development93,713
Selling General Administrative54,162
Selling And Marketing Expenses707,777
Operating Expense1,208,215855,652
 
Net Interest Income (+$)
Interest Income101,208
Interest Expense-101,208
Other Finance Cost-101,208
Net Interest Income-101,208
 
Pretax Income (+$)
Operating Income457,336
Net Interest Income-101,208
Other Non-Operating Income Expenses0
Income Before Tax (EBT)363,180553,029
EBIT - interestExpense = 363,180
361,643
451,322
Interest Expense101,208
Earnings Before Interest and Taxes (EBIT)464,388464,388
Earnings Before Interest and Taxes (EBITDA)494,511
 
After tax Income (+$)
Income Before Tax363,180
Tax Provision-11,529
Net Income From Continuing Ops351,651351,651
Net Income350,114
Net Income Applicable To Common Shares350,114
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,554,131
Total Other Income/Expenses Net-95,693101,208
 

Technical Analysis of Nath Bio-Genes (India) Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nath Bio-Genes (India) Limited. The general trend of Nath Bio-Genes (India) Limited is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nath Bio-Genes (India) Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nath Bio-Genes (India) Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 201.40 < 202.05 < 223.80.

The bearish price targets are: 185.35 > 173.10 > 171.25.

Tweet this
Nath Bio-Genes (India) Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nath Bio-Genes (India) Limited. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nath Bio-Genes (India) Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nath Bio-Genes (India) Limited. The current macd is 2.48551727.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nath Bio-Genes (India) Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Nath Bio-Genes (India) Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Nath Bio-Genes (India) Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nath Bio-Genes (India) Limited Daily Moving Average Convergence/Divergence (MACD) ChartNath Bio-Genes (India) Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nath Bio-Genes (India) Limited. The current adx is 20.43.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nath Bio-Genes (India) Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Nath Bio-Genes (India) Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nath Bio-Genes (India) Limited. The current sar is 188.54.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nath Bio-Genes (India) Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nath Bio-Genes (India) Limited. The current rsi is 64.52. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Nath Bio-Genes (India) Limited Daily Relative Strength Index (RSI) ChartNath Bio-Genes (India) Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nath Bio-Genes (India) Limited. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nath Bio-Genes (India) Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Nath Bio-Genes (India) Limited Daily Stochastic Oscillator ChartNath Bio-Genes (India) Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nath Bio-Genes (India) Limited. The current cci is 162.64.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Nath Bio-Genes (India) Limited Daily Commodity Channel Index (CCI) ChartNath Bio-Genes (India) Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nath Bio-Genes (India) Limited. The current cmo is 44.17.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Nath Bio-Genes (India) Limited Daily Chande Momentum Oscillator (CMO) ChartNath Bio-Genes (India) Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nath Bio-Genes (India) Limited. The current willr is -7.35294118.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Nath Bio-Genes (India) Limited Daily Williams %R ChartNath Bio-Genes (India) Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nath Bio-Genes (India) Limited.

Nath Bio-Genes (India) Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nath Bio-Genes (India) Limited. The current atr is 7.71105759.

Nath Bio-Genes (India) Limited Daily Average True Range (ATR) ChartNath Bio-Genes (India) Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nath Bio-Genes (India) Limited. The current obv is 2,740,333.

Nath Bio-Genes (India) Limited Daily On-Balance Volume (OBV) ChartNath Bio-Genes (India) Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nath Bio-Genes (India) Limited. The current mfi is 66.91.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Nath Bio-Genes (India) Limited Daily Money Flow Index (MFI) ChartNath Bio-Genes (India) Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nath Bio-Genes (India) Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Nath Bio-Genes (India) Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nath Bio-Genes (India) Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.523
Ma 20Greater thanMa 50191.625
Ma 50Greater thanMa 100196.026
Ma 100Greater thanMa 200203.381
OpenGreater thanClose201.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nath Bio-Genes (India) Limited with someone you think should read this too:
  • Are you bullish or bearish on Nath Bio-Genes (India) Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nath Bio-Genes (India) Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nath Bio-Genes (India) Limited

I send you an email if I find something interesting about Nath Bio-Genes (India) Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Nath Bio-Genes (India) Limited.

Receive notifications about Nath Bio-Genes (India) Limited in your mailbox!